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Several proteins at endoplasmic reticulum (ER)-Golgi
membrane contact sites contain a PH domain that
interacts with the Golgi phosphoinositide PI(4)P, a
FFAT motif that interacts with the ER protein VAP-
A, and a lipid transfer domain. This architecture
suggests the ability to both tether organelles and
transport lipids between them. We show that in oxy-
sterol binding protein (OSBP) these two activities are
coupled by a four-step cycle. Membrane tethering
by the PH domain and the FFAT motif enables sterol
transfer by the lipid transfer domain (ORD), followed
by back transfer of PI(4)P by the ORD. Finally, PI(4)P
is hydrolyzed in cis by the ER protein Sac1. The
energy provided by PI(4)P hydrolysis drives sterol
transfer and allows negative feedback when PI(4)P
becomes limiting. Other lipid transfer proteins are
tethered by the same mechanism. Thus, OSBP-
mediated back transfer of PI(4)P might coordinate
the transfer of other lipid species at the ER-Golgi
interface.
INTRODUCTION
Membrane contact sites (MCSs) are regions where the mem-
branes of two organelles are closely apposed, typically 10–
20nmapart (FriedmanandVoeltz, 2011;Helle et al., 2013; Levine,
2004). In a few cases, such structures are obvious by thin-section
electron microscopy (EM) as the two membranes are aligned
along significant distances. The best examples are contact sites
between the endoplasmic reticulum (ER) and the plasma mem-
brane (PM) in yeast (Manford et al., 2012; West et al., 2011). In
most cases, however,moreelaboratemorphological approaches
are required; for example, EM tomography of cryo-fixed prepara-
tions identified MCSs between a specialized region of the ER,
called trans ER, and the trans Golgi (Ladinsky et al., 1999).
MCSs are diverse, but a recurrent observation is the involve-
ment of the ER (Friedman and Voeltz, 2011; Helle et al., 2013;830 Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc.Levine, 2004). By making an extensive network, the ER is indeed
in the best position to contact other cellular organelles. In addi-
tion, because the ER is the main site for lipid synthesis, MCSs
suggest ways to supply lipids to a secondmembranewith limited
lipid synthesis ability. This hypothesis is supported by the pres-
ence of proteins with lipid exchange activity in manyMCSs (Helle
et al., 2013; Lev, 2010; Levine, 2004).
MCSs between the ER and the Golgi contain the following lipid
transporters: CERT, which transports ceramide (Hanada et al.,
2003); FAPP2, which transports glucosylceramide (D’Angelo
et al., 2007); Sec14/Nir2, which transports phosphatidylinositol
(Litvak et al., 2005); and OSBP, which might transport choles-
terol (Perry and Ridgway, 2006). ER-to-Golgi transfer of cer-
amide and glucosylceramide by CERT and FAPP2 are of key
functional importance because they are mandatory for the syn-
thesis of sphingomyelin and glycosphingolipids by enzymes pre-
sent only in the trans Golgi (D’Angelo et al., 2007; Hanada et al.,
2003). The function of OSBP is less clear, and it has been pro-
posed that OSBP and related proteins (ORP in mammals, Osh
in yeast) either sense or transfer sterols (Beh et al., 2012; Beh
and Rine, 2004; Mousley et al., 2012; Raychaudhuri et al.,
2006; Wang et al., 2005). Nevertheless, the presence of OSBP
in zones where CERT and FAPP2 act is intriguing because coen-
richment in sphingolipids and cholesterol is a hallmark of late
(trans Golgi, endosomes and PM), as opposed to early (ER and
cis Golgi), compartments. OSBP and other lipid transporters
might work in a coordinated manner to control the composition
of the trans Golgi using the reservoir of lipids present in the ER
(Lev, 2010; Peretti et al., 2008).
OSBP, FAPP2, and CERT share a similar domain organization
consisting of an N-terminal pleckstrin homology (PH) domain, a
central FFAT motif (two phenylalanines in an acidic track), and
a C-terminal lipid transport domain (Lev, 2010; Levine, 2004).
The PH domain detects two determinants of the trans Golgi:
the phosphoinositide PI(4)P and the small G protein Arf1-GTP
(Godi et al., 2004; Levine and Munro, 2002). On the other hand,
the FFAT motif binds specifically the type II ER membrane pro-
tein VAP (Furuita et al., 2010; Kaiser et al., 2005; Loewen et al.,
2003; Mikitova and Levine, 2012). Thus, OSBP, FAPP2, and
CERT are equipped to bridge the ER and the Golgi, although
this tethering activity has not been recapitulated in vitro. As for
their C-terminal regions, they are structurally diverse and corre-
spond to domains that can extract specific lipid species; for
example, the OSBP-related domain (ORD) in the case of OSBP
(Im et al., 2005) or the START domain in the case of CERT
(Kudo et al., 2008). Overall, and despite differences between
these transporters, their domain organization suggests a similar
division of labor between the PH-FFAT tandem, which might
bridge the ER and the Golgi, and the C-terminal domain, which
conveys specific lipids between the two membranes.
OSBP has recently been identified as the target of several anti-
cancer and antiviral compounds (Arita et al., 2013; Burgett et al.,
2011) pointing to its important role in cellular homeostasis. How-
ever, how OSBP and its relatives function at membrane inter-
faces is poorly understood. Here, we use a combination of
reconstitutions on artificial membranes and cellular approaches
to address the mechanism of membrane tethering and lipid
transfer by OSBP, as well as the coupling between these
activities. We show that the PH-FFAT region of OSBP bridges
membranes containing the ER protein VAP-A to membranes
containing PI(4)P or Arf1-GTP. Furthermore, membrane bridging
directs sterol transfer by the ORD domain. Surprisingly, how-
ever, the ORD domain in turn controls membrane tethering by
the PH-FFAT region. This feedback is due to two additional reac-
tions. First, PI(4)P is transported by the ORD domain, which, like
the yeast protein Osh4, acts as a sterol/PI(4)P exchanger (de
Saint-Jean et al., 2011). Second, PI(4)P, once transported back
from the Golgi to the ER, becomes accessible to the PI(4)P phos-
phatase Sac1, which, in contrast to a previous report (Stefan
et al., 2011), preferentially hydrolyzes PI(4)P in cis rather than
in trans. This first complete reconstitution of a lipid transporter
at ER-Golgi contact sites suggests a general way to couple a
specific lipid transfer reaction with the back transfer and hydro-
lysis of PI(4)P.
RESULTS
OSBP Contains a Potent Membrane Tethering Region
but Is Predominantly Cytosolic
To determine the ability of OSBP to tether the ER to the Golgi,
we first compared the localization of full-length OSBP and a
construct encompassing the PH domain, the coiled-coil region
and the FFAT motif (PH-FFAT; Figure 1A). Both constructs
were tagged with mCherry and cotransfected with a GFP version
of the ER receptor VAP-A (GFP-VAP-A) in HeLa cells.
Figure 1B and Figure S1A (available online) show that OSBP
is predominantly cytosolic, with some faint staining of the ER
network, which ismarked byGFP-VAP-A. In agreement with pre-
vious observations (Ridgway et al., 1992), the addition of the
oxysterol 25-OH induced a dramatic shift in the localization of
OSBP, which translocated completely to perinuclear structures
(Figure S1A). This shift was accompanied by the displacement
of VAP-A, which no longer decorated the ER network, but
instead concentrated in the same perinuclear regions as OSBP
(Figure 1B).
In contrast to OSBP, PH-FFATwas never cytosolic: even in the
absence of 25-OH, it localized to perinuclear regionswhere VAP-
A, but not a mutant deficient in FFAT motif binding (KM > DD),
concentrated (Figures 1C and S1A). These regions were alsopositive for the trans Golgi marker TGN-46 (Figure S1B), thereby
suggestive of ER-Golgi MCSs.
To further characterize the perinuclear regions where VAP-A
and the OSBP constructs concentrated, we used thin-section
EM. We observed extensive ER/Golgi apposed regions in cells
treated with 25-OH and expressing VAP-A and OSBP, as well
as in untreated cells expressing VAP-A and PH-FFAT (Figures
1D, S1C, and S1D). In some cases, Golgi cisternae and vesicles
were completely enwrapped by the ER and lipid bilayers were
systematically paired at an even distance of 20 nm. Fluores-
cence recovery after photobleaching (FRAP) indicated that
VAP and OSBP or PH-FFAT exchanged very slowly from such
zones (t1/2 > 5 min) compared to conditions where VAP and
the OSBP constructs do not colocalize (Figures 1E and 1F).
We introduced point mutations in PH-FFAT to determine the
molecular basis of membrane tethering. The R108L mutation,
which prevents the interaction of the PH domain with PI(4)P
(Levine and Munro, 2002), shifted the localization of PH-FFAT
toward the ER (Figure S1E). Conversely, mutating the FFAT
motif shifted the localization of PH-FFAT toward the Golgi
(Figure S1E). Intriguingly, when the same mutations were intro-
duced in full-length OSBP, the membrane association of this
essentially soluble protein increased: the PH domain mutation
promoted OSBP binding to the ER, whereas the FFAT motif
mutation promoted OSBP binding to the Golgi (Figure S1F).
Therefore, whereas the PH domain and the FFAT motif have
additive effects for the localization of PH-FFAT at ER-Golgi
MCS, they have a curious subtractive effect in the context of
full-length OSBP.
These experiments indicate that the PH-FFAT tandem of
OSBP is a very potent bridge to connect ER and Golgi mem-
branes and that it does so by binding VAP-A via its FFAT motif
and PI(4)P via its PH domain. However, in the context of full-
length OSBP, the availability of the PH-FFAT tandem for mem-
brane tethering is reduced and can be controlled by 25-OH,
which targets the ORD.
Reconstitution of Membrane Tethering by the PH-FFAT
Region of OSBP
We wished to recapitulate membrane tethering by the PH-FFAT
tandem of OSBP in minimal systems. For this, we mixed purified
PH-FFAT with two types of artificial liposomes (Figure 2A). Lipo-
somes La contained a nickel lipid (DOGS-NiNTA) to which the
cytosolic domain of VAP-A was attached through a C-terminal
polyhistidine tag; liposomes Lb contained PI(4)P and/or were
covered by Arf1-GTP (Figure 2B). As such, La and Lb mimicked
the ER and the Golgi apparatus, respectively.
We first used dynamic light scattering (DLS) to follow liposome
aggregation. Initially, the La + Lb mixture showed an apparent
radius of 70 nm. Upon PH-FFAT addition, the radius increased
steadily, reaching values in the range of 500 nm within tens of
minutes, suggesting massive liposome aggregation (Figure 2C),
which was confirmed by negative stained EM (Figure 2D). Con-
trol experiments indicated that aggregation required VAP-A
on La and Arf1-GTP or PI(4)P on Lb. At low tether concentration,
the effects of Arf1-GTP and PI(4)P were additive; at high tether
concentration, efficient tethering was observed with either
Arf1-GTP or PI(4)P (Figure 2C).Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc. 831
Figure 1. The PH-FFAT Region of OSBP Promotes ER-Golgi Tethering
(A) Domain organization of OSBP and of the PH-FFAT construct.
(B) HeLa cells coexpressing GFP-VAP-A and mCherry-OSBP; VAP-A labels the ER network, whereas OSBP is mostly cytosolic (top). Upon addition of 25-OH
(6.5 mM, for 1 hr at 37C), OSBP translocates to a perinuclear region where VAP-A also concentrates.
(C) HeLa cells expressing GFP-VAP-A and PH-FFAT-mCherry; the latter is enriched in perinuclear structures in which GFP-VAP-A concentrates. The VAP-A
mutant deficient in FFAT binding (VAP-A KM > DD) remains spread in the ER network.
(D) Thin-section EM of cells expressing GFP-VAP-A and PH-FFAT-mCherry or mCherry-OSBP. Extended membrane-apposed regions are observed in cells
treated by 25-OH and coexpressing VAP-A and OSBP and in cells coexpressing VAP-A and PH-FFAT. Magnifications of ER digitations within Golgi stacks are
shown on the right.
(E and F) FRAP analysis of cells coexpressing GFP-VAP and PH-FFAT-mCherry (E) or GFP-VAP and mCherry-OSBP in the presence or in the absence of 25-OH
(F). The traces show the mean of at least three experiments. Shaded areas represent SD.
See also Figure S1.To further analyze PH-FFAT-mediated membrane tethering,
we used artificial membranes that can be visualized by light mi-
croscopy, namely giant liposomes and bead-supported bilayers,
which were labeled with red and green fluorescent lipids,
respectively. PH-FFAT promoted the formation of extended con-832 Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc.tact zones between the giant liposomes, which carried VAP-A,
and the bead-supported bilayers, which carriedPI(4)P (Figure 2E;
Movie S1). Contact zones were also observed when PH-FFAT
was added to two populations of bead-supported bilayers with
a similar segregation of membrane determinants (Figure 2F).
Figure 2. Reconstitution of Membrane Tethering by the PH-FFAT Region of OSBP
(A) Experimental strategy.
(B) Binding of the various constructs to liposomes La or Lb.
(C) Aggregation of La and Lb liposomes by PH-FFAT as followed by DLS. The determinants present on La and Lb are indicated in the table (VAP-A: 0.2 mM;
accessible PI(4)P: 0.2 mM; Arf1-GTP: 0.2 mM).
(D) Electron micrographs of liposomes incubated with PH-FFAT as in (C).
(E) Confocal microscopy images of giant liposomes (red) covered with VAP-A through the nickel lipid DOGS-NiNTA andmixed with bead-supported lipid bilayers
(green) containing 2 mol % PI(4)P and with or without PH-FFAT.
(F) Same as in (E) with two populations of bead-supported bilayers.
See also Figure S2 and Movie S1.Full-Length OSBP Promotes Membrane Tethering
In Vitro Independently of 25-OH
Using the same assays, we compared the tethering activity of
purified full-length OSBP to that of PH-FFAT. Given our cellular
observations (Figure 1), we expected OSBP to be much less
active than PH-FFAT. Surprisingly, OSBP readily promoted
the tethering of lipid membranes containing Arf1-GTP and/or
PI(4)P to lipid membranes containing VAP-A. In fact, under all
conditions tested, OSBP was at least as efficient as PH-FFAT
(Figures S2A–S2C). Furthermore, 25-OH, which promotes
OSBP-mediated membrane tethering in cells, did not influence
the tethering activity of OSBP in these reconstituted systems
(Figure S2D). Thus, whereas the tethering activities of PH-FFAT
in vivo and in vitro matched well (compare Figures 1C and 2),this was not the case for OSBP, which efficiently connected
membranes in vitro (Figure S2), but not in cells, except in the
presence of 25-OH (Figure 1B).
OSBP Changes the Cellular Distribution of Sterol and
PI(4)P
Despite the lack of observable association of OSBP with organ-
elles, wewondered whether the protein affects the distribution of
its two putative lipid ligands: cholesterol and PI(4)P.
To follow the distribution of PI(4)P, we used a GFP fusion of
the PH domain of OSBP, which has been shown to be a fair
reporter of PI(4)P levels at the Golgi (Levine and Munro, 2002).
In control cells, the PI(4)P probe stained the Golgi apparatus
and showed minor cytosolic distribution (Figure 3A). In contrast,Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc. 833
Figure 3. OSBP Affects the Cellular Distribution of Sterol and PI(4)P
(A) HeLa cells were transfected with a PI(4)P probe and various mCherry-OSBP constructs. The plot shows the amount of the PI(4)P probe in the perinuclear
region. Measurements were performed on 50–80 cells for each condition using widefield fluorescence microscopy. Horizontal bars represent median values of
the samples.
(legend continued on next page)
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overexpression of OSBP caused a 3.5-fold drop in the Golgi
staining by the probe (Figure 3A), suggesting a large decrease
in the amount of PI(4)P in this organelle. Experiments using
different forms of OSBP indicated that this decrease required a
fully functional protein. First, mutations that compromise the
interaction of OSBP with either VAP-A (mutation FF > AA in the
FFAT motif) or PI(4)P (mutation R108L in the PH domain) made
OSBP less efficient in reducing the PI(4)P level. Second,
mutating two histidines and one lysine, which are strictly
conserved in the ORD and essential for the extraction of PI(4)P
by Osh4p (de Saint-Jean et al., 2011), abolished the drop in
PI(4)P (Figures 3A and S3A). PH-FFAT, which lacks the ORD,
also did not affect the localization of the PI(4)P probe. Third,
25-OH reversed the effect of OSBP on PI(4)P levels, causing
relocalization of the PI(4)P probe to the Golgi (Figure 3A). Taken
together these experiments suggest that OSBP controls the
turnover of PI(4)P at the Golgi in a manner that involves its PH
domain, its FFAT motif and its ORD. This effect requires the pro-
tein to not be blocked by 25-OH and involves the same residues
that enable Osh4p to extract PI(4)P.
Visualizing cholesterol levels in cells is challenging due to its
broad subcellular distribution and the lack of organelle-specific
probes for this lipid. As a first step toward assessing the effect
of OSBP on sterol trafficking, we pulse-labeled cells with dehy-
droergosterol (DHE), a naturally fluorescent analog of choles-
terol, and chased it with an excess of cholesterol (Figure 3B).
DHE can substitute for cholesterol because both have a very
similar chemical structure in contrast to artificial fluorescent
analogs (Mukherjee et al., 1998). In control cells, the exogenous
addition of DHE caused immediate staining of the PM, followed
within a few minutes of internal membranes and, after 1–2 hr, of
lipid droplets (Figure 3B), indicative of a retrograde route from
the PM to the ER, where lipid droplets form. In contrast, overex-
pression of OSBP, but not of PH-FFAT, prevented DHE incorpo-
ration in lipid droplets (Figure 3B). These experiments suggest
that OSBP counteracts the retrograde traffic of sterols. However,
they do not indicate at which location OSBP prevents this flux.
Howcan the inhibition of the fluxof sterol fromPM to lipid drop-
lets be linked to the reduction of theGolgi pool of PI(4)P? The first
effect leavesmany possibilities for the exact site of OSBP action,
whereas the second effect suggests that OSBPworks at the ER-
Golgi interface. Interestingly, mutations predicted to abolish PI(4)
P binding (Figure S3A) prevented OSBP from counteracting the
accumulation of DHE in lipid droplets (Figure 3B), suggesting
that the two activities of OSBP are coupled.
Cholesterol is esterified and incorporated into lipid droplets
when its level at the ER is high. Therefore, we hypothesized(B) Epifluorescence images of HeLa cells pulse-chased with DHE and subsequen
labeled with the lipid-droplet marker LipidTOX green 15min prior imaging. Note th
transfected cells, but not in control cells or in cells transfected with the indicated O
with the lipid droplets from three independent experiments.
(C) HeLa cells were transfected with a PI(4)P probe and with or without mCherry-O
medium supplemented with 5% lipoprotein-deprived serum. Thereafter and 2 h
cholesterol biosynthesis. Under these conditions, OSBP does not promote disap
Golgi were determined from two control experiments where HeLa cells expressing
5 min) to block PI(4)P biosynthesis. Measurements were performed on 40 to 50
(D) In contrast to wild-type mCherry-OSBP, the H522A/H523A, K736A, and triple
See also Figure S3.that OSBP exports sterol out of the ER at the expense of sterol
incorporation into lipid droplets and in a manner that ‘‘con-
sumes’’ PI(4)P at the Golgi. Specifically, OSBP might exchange
the two lipids at the ER-Golgi interface. Measuring such an
exchange in vivo and in the confined environment of Golgi/ER
MCSs was, however, not possible. To determine if OSBP acts
on the pool of cholesterol present in the ER, we used an alterna-
tive strategy: we lowered the level of cholesterol at the ER using
lovastatin. As shown in Figures 3C and S3B, this treatment pro-
tected the pool of PI(4)P at the Golgi from being consumed by
OSBP, which became trapped at the ER-Golgi interface. We
concluded that OSBP controls the balance between sterol at
the ER and PI(4)P at the Golgi.
Altogether, the experiments of Figures 3 and S3 suggest that
the apparent cytosolic localization of OSBP is deceptive and
masks an ephemeral interaction with the ER and the Golgi. In
the case of PH-FFAT, we observe stable tethering because
this construct acts solely as an ER-Golgi bridge. In contrast,
OSBP via its ORD displaces PI(4)P from the Golgi (Figure 3A).
Because PI(4)P contributes to the Golgi attachment of OSBP
(via the PH domain), its displacement should eventually interfere
with membrane tethering. In line with this hypothesis, OSBP
mutants predicted to be deficient in PI(4)P transfer not only pre-
served the Golgi localization of the PI(4)P probe (Figure 3A) but
also remained concentrated at ER-Golgi MCSs (Figure 3D).
Therefore, OSBP might be controlled by a negative feedback
loop whereby membrane tethering promotes sterol/PI(4)P ex-
change, which in turn impairs membrane tethering.
OSBP Is Autoinhibited for Sterol Transport
As a first step toward testing this feedback model, we assessed
the lipid transport activity of OSBP in vitro. OSBP did not accel-
erate the exchange of the sterol DHE between liposomes that
contained no determinants to promote binding of the PH-FFAT
region (Figure 4A, black trace). We then submitted OSBP
to limited proteolysis and observed a dramatic acceleration of
DHE transfer, which paralleled the first steps of OSBP cleavage
(Figure 4A, red traces). These results suggest that OSBP is auto-
inhibited for sterol exchange.
We analyzed the products of the proteolysis using N-terminal
sequencing and gel filtration chromatography (Figures 4B, 4C,
and S4). This analysis revealed a few major products: (1) a
43 kDa fragment encompassing the PH domain and the FFAT
motif, (2) a 35 kDa fragment derived from the previous one but
lacking the FFAT motif, (3) various fragments of 30–35 kDa cor-
responding to the N-terminal part of the ORD, and (4) a 20 kDa
fragment corresponding to the remaining region of the ORD. Intly incubated for 2 hr at 37C with 500 mM cholesterol-loaded MCD. Cells were
e absence of colocalization between DHE and LipidTOX in the mCherry-OSBP-
SBP mutants. Histogram represent quantification (±SE) of DHE colocalization
SBP. To lower ER cholesterol, the cells were first incubated overnight in growth
r before imaging, 15 mM lovastatin was added to the medium in order to stop
pearance of PI(4)P from the Golgi. Maximal and minimal PI(4)P staining at the
the PI(4)P probe only were treated or not with phenylarsine oxide (PAO, 10 mM,
cells for each condition using confocal microscopy.
mutants concentrated with VAP-A in the perinuclear region.
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Figure 4. Analysis of Trypsin-Digested OSBP
(A) Time course of DHE transfer between donor and acceptor liposomes (63 mM lipids each) containing 18%DHE and 2.5%Dansyl-PE, respectively. Transfer was
initiated by the addition of 1 mMMCD (gray trace), 0.1 mMOSBP (black trace), or the same amount of OSBP after digestion with trypsin for 1, 3, or 7 min at 30C
(light to dark red curves). Trypsin digestion was analyzed by SDS-PAGE.
(B) OSBP fragments generated by trypsin as identified by N-terminal sequencing.
(C) OSBP fragments from a 5 min digestion with trypsin were resolved by size-exclusion chromatography. Fractions were analyzed by SDS-PAGE and tested for
DHE transfer (gray bars) and liposome tethering as in Figure 2C (red dots represent mean radius ± polydispersity).
See also Figure S4.gel filtration chromatography, the first two products eluted at an
apparent molecular weight (MW) of about 80 kDa, suggesting
dimerization through coiled-coil regions between the PH domain
and the FFATmotif. The ORD fragments (30–35 and 20 kDa) coe-
luted at a MW of 50 kDa, suggesting that cleavage of the ORD at
position R669-G670 does not promote separation of the domain
parts. Membrane tethering activity was present in the first
gel-filtration peak, whereas DHE exchange activity was present
predominantly in the second peak (Figure 4C). This analysis
confirms the division of labor in OSBP: the PH-FFAT tandemme-
diates membrane tethering and the ORD mediates lipid
transport.
Sterol Transfer by OSBP Requires VAP-A and Is
Facilitated by Arf1-GTP
To determine the mechanism by which OSBP becomes active
for sterol transfer, we included various combinations of VAP-A,
Arf1-GTP, and PI(4)P on the liposomes used for the DHE assay.
The red trace in Figure 5A shows a representative time course of
DHE transfer in an experiment where VAP-A was attached to La
and Arf1-GTP was attached to Lb. Under such conditions, the836 Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc.rate of DHE transfer catalyzed by 107 M OSBP was very fast
and close to that observed with 103 M methyl-b-cyclodextrin
(MCD; Figure 5A, gray trace), indicating that OSBP has a
10,000-fold higher exchange activity than the drug.
Removing VAP-A from La abolished OSBP-catalyzed DHE
transfer, whereas removing Arf1-GTP from Lb reduced the rate
3-fold to 5-fold (Figures 5A–5C). Therefore, the interaction of
OSBP with VAP-A is mandatory for sterol exchange, whereas
the interaction with Arf1-GTP is helpful, but not strictly required.
Titration experiments gave a half-stimulatory effect of 300 nM for
VAP-A and of 100 nM for Arf1-GTP (Figures 5B and 5C). From
the amounts of DHE and OSBP present (11 mM and 100 nM,
respectively), we calculated that each cycle of sterol transfer
takes about 2–3 s (k = 0.3–0.5 s1) under optimal conditions
(Figures 5B and 5C). 25-OH blocked OSBP-catalyzed transfer
of DHE with a Ki of 50 nM (Figure 5D), a value compatible with
the reported affinity of 25-OH for OSBP (10 nM) (Ridgway
et al., 1992).
To better characterize the mechanism of OSBP activation,
we conducted experiments with soluble forms of VAP-A and
Arf1-GTP. VAP-A retained a substantial stimulatory effect
Figure 5. Membrane Tethering Controls the
Sterol Transfer Activity of OSBP
(A) DHE transfer assay between liposomes La
(63 mM lipids) and Lb (63 mM lipids) in the presence
of 0.1 mM OSBP or 1 mM MCD. La and Lb were
supplemented with 1 mM VAP-A and 0.1 mM Arf1-
GTP, as indicated.
(B and C) Dose-response curves for the effects of
VAP-A (B) or Arf1-GTP (C) on OSBP-mediated
DHE transfer as measured in (A).
(D and E) Inhibitory effects of 25-OH (D) or the
FFAT peptide (E) on OSBP-mediated DHE trans-
fer. La and Lb contained 1 mM VAP and 0.1 mM
Arf1-GTP, respectively.
See also Figure S5.even in the absence of nickel lipids (Figure S5A), whereas sol-
uble Arf1-GTP had no significant effect (Figure S5B). These
observations suggest that VAP-A not only acts as a mem-
brane anchor but also affects the conformation of OSBP,
whereas Arf1-GTP acts primarily as a membrane anchor.
The importance of the VAP-FFAT interaction in OSBP-medi-
ated DHE exchange was underscored by the effect of a pep-
tide corresponding to the FFAT motif, which completely
blocked DHE transfer (Ki = 0.82 ± 0.15 mM, Figure 5E). As
for the stimulatory effect of Arf1-GTP, it disappeared when
the small G protein was attached to La instead of Lb (Fig-
ure S5B), suggesting that the membrane determinants of
OSBP should be present on different liposomes to promote
lipid exchange.
Complex Effect of PI(4)P on Sterol Transfer by OSBP
In membrane tethering assays, Arf1-GTP and PI(4)P had inter-
changeable roles, both promoting liposome aggregation by
PH-FFAT (Figure 2C). In contrast, the effects of PI(4)P and
Arf1-GTP on DHE transfer by OSBP were very different. In the
presence of PI(4)P in Lb, the kinetics of DHE transfer from La to
Lb displayed a biphasic shape (Figures 6A and S6A). During
the first minute, DHE transfer occurred rapidly. Then, it abruptly
slowed down. Considering that, under our conditions, the overall
transfer of DHE from La to Lb requires about 50 cycles of OSBP-
mediated DHE transfer, this observation suggests that PI(4)P
becomes inhibitory after OSBP has undergone a few cycles
(Figure S6B).
To explain these observations we envisaged that, through
a mechanism akin to Osh4p (de Saint-Jean et al., 2011), the
ORD of OSBP could extract PI(4)P from Lb and transfer it to La.
As such, PI(4)P should gradually inhibit DHE transfer by two
effects: competition with DHE on La for OSBP extraction and
redirection of the PH domain of OSBP from Lb to La. In agree-
ment with the competition hypothesis, PI(4)P strongly and spe-
cifically inhibited DHE transfer by trypsin-activated OSBP; i.e.,
under conditions where the ORD domain is dissociated from
the PH-FFAT tandem (Figure 6B).Cell 155, 830–843,OSBP Is a PI(4)P Transporter
To directly address the ability of OSBP
to transfer PI(4)P, we used a novel assay
based on the detection of PI(4)P by a fluo-rescent PH domain, NBDPH. When PI(4)P is present in unlabeled
liposomes, the fluorescence of membrane-bound NBDPH is
high; whenPI(4)P is present in liposomes containing a rhodamine
lipid (Rho-PE), FRET occurs between NBDPH and Rho-PE at the
expense of NBD fluorescence. As schematized in Figure 6C,
PI(4)P is initially present in Lb, which also contain Rho-PE, result-
ing in low NBDPH fluorescence. PI(4)P transfer to La, which do
not contain Rho-PE, causes an increase in the fluorescence
of NBDPH.
Figure 6C demonstrates that OSBP, but not PH-FFAT, trans-
fers PI(4)P from Lb to La and that this transfer is promoted by
the presence of VAP-A. Of note, whereas OSBP was initially
able to transfer PI(4)P with a rate comparable to that observed
for Osh4p, the reaction slowed down significantly after a few
rounds. As a result, less PI(4)P was transported compared to
the reaction with Osh4p. This observation hints at a possible in-
hibition of OSBP activity as the PI(4)P transfer reaction proceeds,
an effect reminiscent to what we observed for DHE transfer
(Figure 6A).
Control of OSBP-Induced Membrane Tethering by the
PI(4)P Phosphatase Sac1
We reasoned that OSBP, by being able to transfer PI(4)P in a
VAP-A-dependent manner, should, in the context of ER-Golgi
MCS, promote the transfer of PI(4)P from the trans Golgi, which
is rich in this phosphoinositide, to the ER. There, PI(4)P could
be hydrolyzed by the integral ER membrane protein Sac1 (Kim
et al., 2013). This sequence of events would explain why OSBP
reduces the amount of PI(4)P at the Golgi (Figure 3A) and why
the combined effects of the PH domain and the FFAT motif are
subtractive for the localization of full-length OSBP (Figure S1D):
membrane tethering is followed by the transfer and degradation
of PI(4)P, leading to membrane detachment of OSBP.
To test this hypothesis, we first used small interfering RNA
(siRNA) against Sac1 in cells expressingOSBP and VAP-A. Strik-
ingly, knocking down Sac1 completely shifted the localization of
OSBP from an essentially cytosolic distribution to a perinuclear
one where VAP-A colocalized (Figure 7A). Thus, in the cell,November 7, 2013 ª2013 Elsevier Inc. 837
Figure 6. OSBP Transfers PI(4)P between Liposomes
(A) Transfer of DHE between liposomes La (63 mM lipids + 1 mM VAP-A) and Lb (63 mM lipids) in the presence of 0.1 mM OSBP. Lb were supplemented (right) or
not (left) with 0.1 mM Arf1-GTP and contained increasing amounts of PI(4)P. Dashed line is fluorescence observed after DHE equilibration with 1 mM MCD.
(B) PI(4)P specifically inhibits the sterol transfer activity of trypsin-activated OSBP. DHE transfer was carried out as in Figure 4 except that specific phosphoi-
nositides were incorporated at 2 mol % in liposomes La. Rates were normalized to that observed with full-length OSBP (black curve).
(C) Real-time measurement of PI(4)P transfer. NBDPH (250 nM) was mixed with Lb (300 mM lipids + 2 mol % PI(4)P + 2.5 mol % Rho-PE). At t = 60 s, La (300 mM
lipids ± 1 mM VAP) were added followed by Osh4p, OSBP, or PH-FFAT (all at 100 nM) at t = 120 s. Dashed line represents the signal for full equilibration of PI(4)P
between La and Lb.
See also Figure S6.OSBP has the ability to tether ER and Golgi membranes, but
Sac1 counteracts this activity.
Next, we addressed the effect of Sac1 on the tethering activity
of OSBP in vitro. For this, we mixed La and Lb liposomes to
imitate the ER/trans Golgi interface and monitored liposome ag-
gregation by DLS. Liposomes La were coated with both VAP-A
and with Sac1 via their C-terminal polyhistidine tags, which
replaced the juxtamembrane regions of these ER proteins. Lb838 Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc.contained PI(4)P. Thus, PI(4)P and Sac1 were initially present
in different membranes, i.e., in a trans orientation. These exper-
iments revealed a marked difference between full-length OSBP
and PH-FFAT (Figure 7B): membrane tethering induced by
OSBP strongly diminished in the presence of 5 to 10 nM Sac1,
whereas membrane tethering induced by PH-FFAT was more
resistant, diminishing significantly only at Sac1 concentration
above 15 nM.
The experiments shown in Figures 7A and 7B suggest that
Sac1 is the missing link for reconciling the in vitro and cellular
observations. Adding Sac1 to liposome reconstitutions recapit-
ulated the differences in the tethering activities of OSBP and
PH-FFAT that were obvious in cellular experiments (Figures 1B
and 1C). Conversely, depleting Sac1 from cells by siRNA
rendered OSBP as efficient as PH-FFAT in Golgi-ER tethering,
in agreement with our initial liposome reconstitutions where
Sac1 was absent (Figures 2 and S2).
Sac1 Preferentially Hydrolyzes PI(4)P in cis
In Sac1, the catalytic site is cytosolic and is connected to the
transmembrane domain with a putative 17 nm flexible linker. It
has been proposed that this feature allows Sac1 to hydrolyze
PI(4)P in trans, i.e., when PI(4)P is present in an apposed mem-
brane (Stefan et al., 2011). However, we noted that the results
of our tethering assay were more consistent with a cis activity
of Sac1. In this assay, PI(4)P was initially present in trans from
Sac1, yet Sac1 disrupted more efficiently membrane tethering
by OSBP, which should transfer PI(4)P between the liposomes,
than by PH-FFAT, which should leave the trans segregation
unchanged (Figure 7B).
To directly address the optimal orientation of PI(4)P for Sac1-
mediated hydrolysis, we monitored phosphate release using a
green malachite assay. Again, La and Lb liposomes were mixed;
the former contained DOGS-NiNTA to bind Sac1 and VAP-A,
and the latter contained PI(4)P. PH-FFAT, which stably bridges
these liposomes, thereby imposing a trans segregation of Sac1
and PI(4)P, did not promote PI(4)P hydrolysis (Figure 7C, gray cir-
cles). In contrast, OSBP, which transfers PI(4)P from Lb to La,
stimulated PI(4)P hydrolysis in a VAP-A-dependent manner (Fig-
ure 7D). Control experiment in which PI(4)P was directly included
in La demonstrated that Sac1 readily hydrolyzed PI(4)P in cis
(Figure 7C, pink circles).
PI(4)P Hydrolysis by Sac1 Relieves OSBP Blockage
As aforementioned, the gradual inhibitory effect of PI(4)P on
OSBP-catalyzed DHE transfer probably arises from PI(4)P back-
ward transfer to the ER-like membrane (liposomes La), where it
should antagonize DHE extraction. We predicted that Sac1, by
hydrolyzing PI(4)P in cis, should relieve this inhibition. We thus
repeated the DHE transport experiment in the presence of
Sac1, which was attached to La together with VAP-A. As before,
La contained DHE, whereas Lb contained PI(4)P. Strikingly, Sac1
had no effect on the initial fast phase of DHE transfer but strongly
accelerated the second phase in a concentration-dependent
manner (Figure 7E), except when 25-OH was present (Fig-
ure S7A). This observation demonstrates that VAP-A, OSBP,
and Sac1 act in a sequential manner: VAP-A directs the orienta-
tion of OSBP, OSBP exchanges sterol for PI(4)P, and Sac1 spe-
cifically hydrolyses PI(4)P when this lipid becomes in cis. Another
cycle of sterol/PI(4)P exchange can then resume until the pool of
PI(4)P left in Lb is consumed.
DISCUSSION
Our work suggests a minimal model for how three proteins—
the lipid transporter OSBP, the general ER receptor VAP-A,and the PI(4)P phosphatase Sac1—coordinate their activities
to tether membranes, to promote the specific exchange of
lipids between them and to make these events self-regulated
over time. Our model includes four steps (Figure 7F), each of
which we have reconstituted with minimal components: (1)
membrane tethering, (2) forward sterol transfer, (3) backward
PI(4)P transfer, and (4) PI(4)P hydrolysis. This last reaction
makes the cycle irreversible and, when PI(4)P becomes limiting,
acts as a timer to stop membrane pairing. In the following par-
agraphs, we discuss each step separately, and then envisage
their coordination.
Step 1: Membrane Tethering
The PH-FFAT tandem of OSBP is an efficient membrane tether.
In cells, it caused massive pairing of Golgi membranes with the
ER (Figures 1C and 1D). In vitro, it promoted the aggregation
of membranes in an asymmetric manner according to specific
determinants (Figure 2): on the one hand, VAP-A, which interacts
with the FFAT motif (Furuita et al., 2010; Kaiser et al., 2005); on
the other hand, PI(4)P or Arf1-GTP, which interact with the PH
domain (Godi et al., 2004; Levine and Munro, 2002). The next
step will be to determine the structure of the entire PH-FFAT
module. The presence of coiled coils between the PH domain
and the FFATmotif suggests a dimeric rod-like structure (Figures
S7B and S7C). This architecture, which is found in many teth-
ering molecules, combines two advantages: it imposes a tether
length and allows multivalent interactions with the membrane
(Dumas et al., 2001). The predicted coiled coils of OSBP would
give a rod of about 11 nm interrupted by an elbow. When the
sizes of the other domains are taken into account, this length is
compatible with the distance between tethered membranes
observed in cells (20 nm; Figures 1D and S7C).
Step 2: Sterol Transfer
The ability of OSBP to bind sterols and oxysterols is established
(Ridgway et al., 1992). More debated is OSBP’s function in sterol
transfer. It has been argued that the rate of sterol transfer byOsh/
ORP proteins is not fast enough to account for the quick redistri-
bution of cholesterol between organelles (Beh et al., 2012). Using
assays with high temporal resolution, we report a maximal turn-
over rate of 0.5 s1, i.e., 30 DHE transferred per OSBP and per
minute (Figure 5C). This value is much faster than what has
been measured in vitro for the transfer of ceramide by CERT,
which is unambiguously a ceramide transfer protein (Hanada
et al., 2003; Kawano et al., 2006). Therefore, OSBP seems intrin-
sically adapted to quickly transfer sterols between the ER and
the Golgi.
Step 3: PI(4)P Transfer
We previously demonstrated that Osh4p exchanges sterol for
PI(4)P between artificial membranes and resolved the structure
of Osh4p in complex with PI(4)P (de Saint-Jean et al., 2011).
Our experiments indicate that OSBP is also capable of trans-
ferring PI(4)P between membranes (Figure 6C). Furthermore,
mutating conserved residues that allow Osh4p to extract PI(4)P
prevented OSBP from reducing the PI(4)P level at the Golgi (Fig-
ure 3A). Thus, the ORD might be a general fold to exchange
specific lipids with PI(4)P.Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc. 839
Figure 7. Sac1 Regulates OSBP-Mediated Membrane Tethering and Lipid Exchange
(A) HeLa cells expressing GFP-VAP-A and mCherry-OSBP were transfected with scrambled siRNA (control) or Sac1 siRNA and incubated for 24 hr in growth
medium. OSBP and VAP-A moved to perinuclear areas in Sac1-silenced cells.
(B) Liposome tethering assay. The sample contained liposomes La (12.5 mM lipids, 2% DOGS-NiNTA), Lb (12.5 mM lipids, 2% PI(4)P), 1 mM VAP, and increasing
concentrations of Sac1. At t = 100 s, PH-FFAT (0.2 mM, left) or OSBP (0.2 mM, right) was added. Liposome aggregation was followed by DLS. Sac1 drastically
reduced liposome tethering induced by OSBP, but not by PH-FFAT.
(legend continued on next page)
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Step 4: PI(4)P Hydrolysis
PI(4)P is synthesized by specific PI-4-kinases at theGolgi and the
PM, yet its phosphatase, Sac1, is an integral ER membrane pro-
tein (Kim et al., 2013). Recently, a mechanism has been pro-
posed to solve this paradox: that Sac1p hydrolyses PI(4)P in
trans (Stefan et al., 2011). All our results point to the opposite
mechanism, whereby Sac1 hydrolyzes PI(4)P in cis, i.e., in the
same membrane. PH-FFAT, which bridges very efficiently ER
to Golgi membranes, thereby positioning Sac1 in trans toward
PI(4)P, does not affect the cellular distribution of PI(4)P (Fig-
ure 3A). Recapitulating the trans segregation between Sac1
and PI(4)P using two liposome populations and PH-FFAT as a
tether also does not promote PI(4)P hydrolysis (Figure 7C). In
contrast, full-length OSBP, which transfers PI(4)P from trans to
cis membrane, allows PI(4)P hydrolysis by Sac1 (Figure 7D).
Thus, in the context of ER-Golgi MCSs promoted by OSBP,
Sac1works in cis, althoughwe cannot exclude that it acts in trans
in other circumstances. In yeast, Sac1 deletion causes PI(4)P to
redistribute from the Golgi to other membranes, including the ER
(Faulhammer et al., 2007; Roy and Levine, 2004), an observation
that fits with a sequence of events in which PI(4)P hydrolysis
occurs after its transfer from the Golgi to the ER.
Coordination between Membrane Tethering, Lipid
Exchange, and PI(4)P Hydrolysis
PI(4)P hydrolysis by Sac1 allows multiple round of sterol transfer
by OSBP in the presence of VAP-A (Figure 7E). This result dem-
onstrates that OSBP functions in a cyclic manner by using the
metabolic energy of PI(4)P and implies tight coupling between
all steps of the cycle.
Conditions for efficient sterol transfer (step 2) parallel condi-
tions for efficient tethering (step 1) (Figures 2C and 5A), suggest-
ing that OSBP simultaneously contacts the ER and the Golgi
during at least one step of its cycle. In the confined space be-
tween two apposedmembranes, the ORDmust move within dis-
tancesfour times larger than its own size (Figure S7C), implying
a fascinating gymnastic. It seems that the PH-FFAT tandem not
only restricts the diffusion of the ORD, but also plays an active
role. First, the interaction between VAP-A and the FFAT motif
is mandatory for lipid transfer by the ORD (Figures 5 and 6C).
Second, sequence comparison between ORP/Osh proteins
shows that the FFAT motif is localized at fixed distance from
the ORD N terminus, which itself acts as a lid to control accessi-
bility to the lipid-binding pocket (Im et al., 2005). Thus, the FFAT-
VAP-A interaction is probably critical to unlock the ORD.
When OSBP harbors mutations preventing the ORD from
extracting of PI(4)P (Figures 3A and 3D), it can no longer coun-
teract retrograde sterol transport in cells (Figure 3B). Conversely,
lowering the amount of cholesterol in the ER prevents OSBP(C andD) Sac1 phosphatase assay. To test the cis orientation, Sac1 (50 nM)was ad
test the trans orientation, Sac1 (50 nM) was added to a mixture of La containing 2m
with 0.2 mMPH-FFAT (C) or OSBP (D) in the presence of VAP (1 mM).When PI(4)P w
dependent manner. Data represent average (±SE) from 3 to 6 independent expe
(E) Sac1 stimulates DHE transfer. The experimental conditions were the same as
1 mM VAP. Lb contained 10% PI(4)P. Sac1 relieves the inhibition caused by PI(4)
(F) Model of the OSBP cycle. For simplicity, only one OSBP monomer is shown.
See also Figure S7.from displacing PI(4)P form the Golgi (Figure 3C). Therefore, for-
ward transport of sterol by OSBP at MCSs seems coupled to
backward transport of PI(4)P. Direct demonstration of this
coupling will require detecting simultaneously the exchange of
these two lipids at MCSs. This task is very challenging in vivo,
as it implies following the displacement of lipids within distances
of tens of nanometers. In vitro, however, the fact that extended
MCSs with a simple geometry can be recapitulated (Figure 2E;
Movie S1) suggests possibilities for visualizing lipid movements
using fluorescent analogs and probes.
Whereas the causality between membrane tethering (step 1),
sterol transfer (step 2), and PI(4)P back-exchange (step 3) could
be anticipated given the architecture of OSBP and the similarity
between its ORD and Osh4p (Mesmin et al., 2013), the PI(4)P
hydrolysis step (step 4) after retrograde transfer of PI(4)P, seems
counterintuitive: by transferring PI(4)P to the ER where PI(4)P is
hydrolyzed by Sac1, OSBP ‘‘shoots itself in the foot,’’ eliminating
a determinant that contributes to its own attachment. However,
this reasoning is valid when the level of PI(4)P at the Golgi
becomes limiting, i.e., when the trans Golgi looses its identity.
When PI-4-kinases continuously regenerate PI(4)P at the trans
Golgi, OSBP can cycle many times provided that Sac1 hydroly-
ses PI(4)P at the ER. For such an unidirectional cycle to function,
it is essential that PI(4)P hydrolysis occurs in cis; if Sac1 acted in
trans, it would burn PI(4)P prematurely, i.e., before sterol trans-
fer. The OSBP cycle relies fundamentally on the segregation of
VAP-A, Sac1, and PI4-kinases between the ER and the Golgi,
which allows PI(4)P hydrolysis at the ER to provide the energy
for sterol transfer. Interestingly, similar cycles may occur at other
MCS: recent observations indicate that PI-4-kinases contribute
to sterol enrichment at the PM where other ORP/Osh proteins
act (Nakatsu et al., 2012). Because PI(4)P is present not only at
the Golgi but also at the PM, further work is needed to determine
the combinations of membrane determinants that direct the spe-
cific targeting of OSBP and its relatives to different membranes.
We note that the apparent coupling between various lipid
transfer reactions at ER-Golgi MCSs (Peretti et al., 2008; Perry
and Ridgway, 2006) can be explained on the basis of the
OSBP cycle. FAPP2 and CERT rely on the same membrane de-
terminants as OSBP. By controlling the amount of PI(4)P in the
target membrane, OSBP could set the tempo for the delivery
of precursors of complex lipids to the trans Golgi, thereby
insuring that the concentrations of cholesterol and sphingolipids
increase in parallel along the ER-Golgi interface.
CONCLUSIONS
The sequence of reactions that we demonstrate for OSBP invites
a comparison with ion pumps. Through the use of metabolicded to liposomes La containing 2mol%DOGS-NiNTA and 20mol%PI(4)P. To
ol % DOGS-NiNTA and Lb containing 20 mol% PI(4)P. La and Lb were bridged
as initially present in trans, PI(4)P hydrolysis occurred in anOSBP- and VAP-A-
riments.
in Figure 6A except that increasing amounts of Sac1 were added. La contained
P after a few rounds of lipid transfer.
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energy (phosphorylation and dephosphorylation of a catalytic
residue), ions pumps cycle up to 100 times/s to maintain an
asymmetric distribution of ions across lipid membranes (Palmg-
ren and Nissen, 2011). Functionally, the OSBP cycle seems
analogous, except that it helps to maintain an asymmetric distri-
bution of lipids across a hydrophilic barrier using the metabolic
energy of phosphoinositides.
EXPERIMENTAL PROCEDURES
Protein expression, purification, limited proteolysis, and gel filtration, as well
as cell-culture conditions, transfections, and imaging, are described in the
Extended Experimental Procedures.
Liposomes
The default composition of liposomes La and Lb was egg PC/brain PS/DOGS-
NiNTA (93/5/2 mol %) and egg PC/liver PE/brain PS/liver PI (66/19/5/
10 mol %), respectively. Depending on the assay, DHE, Dansyl-PE, Rhoda-
mine-PE, Oregon green-DHPE, and/or PI(4)P were included in the lipid compo-
sition as indicated. See the Extended Experimental Procedures for additional
details.
Liposome Aggregation
Liposome aggregation was followed by DLS onmixtures containing liposomes
La (25 mM lipids) ± VAP-A (200–250 nM) ± Sac1, and liposomes Lb (25 mM
lipids) ± 200 nM Arf1-GTP ± 2 mol % PI(4)P. Aggregation was initiated by
the addition of 100–250 nM PH-FFAT or 250 nM OSBP and was followed at
30C by acquiring one autocorrelation curve every 10 s. Data were analyzed
assuming a single Gaussian distribution, thus giving an average radius. See
the Extended Experimental Procedures for additional details.
Tethering Assay with Giant Liposomes and Templates
Giant liposomes (type La + 2% Rhodamine-PE) were prepared by sponta-
neous formation. Bead-supported bilayers were prepared by incubating
5 mm silica beads for 30 min with liposomes (type Lb, 200 mM, 2% Oregon
green-DHPE). Tethering was initiated by adding the giant liposomes loaded
with 250 nM VAP-A to the bead-supported bilayers (5 mM lipids) in the pres-
ence of 250 nM PH-FFAT or OSBP. Fluorescence images were acquired
with a confocal microscope using a 633 objective. See the Extended Experi-
mental Procedures for details.
DHE Microscopy
DHE imaging was carried out using a Leica DMIRBE microscope equipped
with an Andor iXon3 blue-optimized EMCCD camera and Semrock BrightLine
fluorescence filters (320/40 nm bandpass filter, 347 nm dichroic beamsplitter,
and 390/40 nm bandpass filter). Images were acquired using a 1003/1.3 oil
objective. See the Extended Experimental Procedures for additional details.
DHE and PI(4)P Transfer Assays
For DHE transfer, the sample initially contained liposomes Lb (±PI(4)P ± Arf1-
GTP) and VAP-A-His, FFAT peptide, or 25-OH as indicated. Liposomes La
(18% DHE) and OSBP were then added. FRET between DHE and Dansyl
was measured at 525 nm (excitation: 310 nm). For PI(4)P transfer, liposomes
Lb (2% Rho-PE) were incubated with
NBDPH and with VAP-A as indicated.
NBD emission was measured at 510 nm (excitation 460 nm). At the indicated
times, liposomes La and OSBP were added. See the Extended Experimental
Procedures for details.
Sac1 PI(4)P Hydrolysis Assay
Liposomes La were incubated with Sac1 and with the indicated amounts
of VAP-A and OSBP or PH-FFAT. The reaction was initiated by the addition
of liposomes Lb (20%PI(4)P). At the indicated times, an aliquot waswithdrawn,
mixed with 50 mM NEM, and supplemented with malachite green reagent for
phosphate quantification. For the experiment in the cis orientation, La were
supplemented with 20% PI(4)P. See the Extended Experimental Procedures
for additional details.842 Cell 155, 830–843, November 7, 2013 ª2013 Elsevier Inc.SUPPLEMENTAL INFORMATION
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